Episode 11 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 3 Tailoring Treatment: The Role of Serotype Testing
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Episode 11 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 3 Tailoring Treatment: The Role of Serotype Testing
-
ナレーター：
-
著者：
このコンテンツについて
Join Dr. Nicholas Silvestri in this 9-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, Tailoring Treatment: The Role of Serotype Testing, discusses the impact of serotype testing on treatment decisions, including differences in therapeutic approaches for AChR-positive, MuSK-positive, and LRP4-positive patients.
Launch Date: April 24, 2025
Release Date: April 24, 2025
Expiration Date: March 31, 2026
FACULTY
Nicholas Silvestri, MD, FAAN
Professor of Neurology, Associate Dean for Student and Academic Affairs
Department of Neurology
Jacobs School of Medicine & Biomedical Sciences
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.